Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Medidata Solutions Inc    MDSO

Delayed Quote. Delayed  - 09/28 10:00:00 pm
56.67 USD   +1.11%
09/20 MEDIDATA : Polaris Pharmaceuticals Adopts Medidata Payments
09/14 MEDIDATA : University of North Carolina Wilmington Partners with Med..
09/07 MEDIDATA : to Present at Deutsche Bank 2016 Technology Conference
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Medidata Solutions Inc : Medidata Solutions Announces Two-for-One Stock Split

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/11/2013 | 12:31pm CEST

Medidata Solutions (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its Board of Directors approved a two-for-one (2:1) split of the Company's common stock at a regularly scheduled board meeting on November 7, 2013. The stock split will be structured in the form of a stock dividend.

The record date for the stock split is December 2, 2013. Shareholders of record as of such date will receive one new share of common stock for each share that they own. The distribution of the new shares will be made on December 16, 2013, and trading on a split-adjusted basis is expected to begin on or about December 17, 2013.

Medidata had approximately 26.8 million shares of common stock outstanding as of November 7, 2013. The stock split will increase the common shares outstanding to approximately 53.6 million.

About Medidata Solutions

Medidata Solutions is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud TM brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of our global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Investors:
Medidata Solutions
Hulus Alpay, 212-419-1025
halpay@mdsol.com
or
Media:
Medidata Solutions
Gail Janowitz, 212-918-1792
gjanowitz@mdsol.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MEDIDATA SOLUTIONS INC
09/20 MEDIDATA : Polaris Pharmaceuticals Adopts Medidata Payments
09/14 MEDIDATA : University of North Carolina Wilmington Partners with Medidata to Bri..
09/07 MEDIDATA : to Present at Deutsche Bank 2016 Technology Conference
09/07 MEDIDATA : and Techfields Launch mHealth Stroke Study
09/06 MEDIDATA : and SHYFT Analytics Form Commercial Partnership
09/01 MEDIDATA : to Present at Citi 2016 Global Technology Conference
08/30 SHYFT ANALYTICS : Raises $12.5 Million in New Funding From Global Healthcare and..
08/15 MEDIDATA SOLUTIONS, INC. : Change in Directors or Principal Officers, Financial ..
08/05 MEDIDATA SOLUTIONS : Management's Discussion and Analysis of Financial Condition..
08/03 MEDIDATA SOLUTIONS : Pluristem Therapeutics Deploys Medidata's Cloud Technology
More news
Sector news : IT Services & Consulting - NEC
08:45pDJApple and Deloitte Form Enterprise Service
08:49aDJBusiness Watch -- WSJ
09/27DJSALESFORCE COM : Enters Ecommerce Fray
09/27DJDisney Considers Offer for Twitter
09/26DJDisney Working With Adviser on Possible Twitter Bid -Bloomberg
More sector news : IT Services & Consulting - NEC
News from SeekingAlpha
07/20 TECHNOLOGY - TOP 5 GAINERS / LOSERS : 00 pm
07/20 Medidata Solutions (MDSO) Tarek A. Sherif on Q2 2016 Results - Earnings Call ..
07/20 Medidata Solutions +10% on EPS, revenue beat
07/20 Medidata Solutions beats by $0.01, beats on revenue
07/19 Notable earnings before Wednesday?s open
Advertisement
Financials ($)
Sales 2016 462 M
EBIT 2016 99,1 M
Net income 2016 20,1 M
Debt 2016 31,9 M
Yield 2016 -
P/E ratio 2016 157,58
P/E ratio 2017 117,48
EV / Sales 2016 7,04x
EV / Sales 2017 5,76x
Capitalization 3 222 M
More Financials
Chart MEDIDATA SOLUTIONS INC
Duration : Period :
Medidata Solutions Inc Technical Analysis Chart | MDSO | US58471A1051 | 4-Traders
Full-screen chart
Technical analysis trends MEDIDATA SOLUTION...
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 57,4 $
Spread / Average Target 2,5%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Tarek A. Sherif Chairman & Chief Executive Officer
Glen Michael de Vries President & Director
Michael L. Capone Chief Operating Officer
Rouven Bergmann Chief Financial & Accounting Officer
Andrew Newbigging Senior Vice President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MEDIDATA SOLUTIONS INC13.71%3 186
INTERNATIONAL BUSINESS..13.92%147 181
TATA CONSULTANCY SERVI..-1.44%71 167
INFOSYS LTD-6.41%35 615
COGNIZANT TECHNOLOGY S..-9.36%32 866
NETEASE INC (ADR)34.71%31 709
More Results